Premium
In systemic pseudohypoaldosteronism type 1 skin manifestations are not rare and the disease is not transient
Author(s) -
Hanukoglu Aaron,
Hanukoglu Israel
Publication year - 2018
Publication title -
clinical endocrinology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.055
H-Index - 147
eISSN - 1365-2265
pISSN - 0300-0664
DOI - 10.1111/cen.13730
Subject(s) - tel aviv , citation , medicine , library science , classics , pediatrics , history , computer science
We read with interest the recent paper by Turan et al. (published online April 18, 2018) on eight patients with hypoaldosteronism resulting from biosynthetic defects of aldosterone secretion (3 cases) or aldosterone insensitivity syndromes named as pseudohypoaldosteronism type 1 (PHA) (5 cases). In 1991, we described for the first time that PHA type I may appear in two forms with distinct clinical, genetic, and endocrine characteristics. These two forms were named as the renal form, and the systemic (multi-system) form of PHA. This article is protected by copyright. All rights reserved.